-
RG7388: From p53 Reactivation to Assay Design
2026-08-14
RG7388 is a selective MDM2 antagonist for studying p53 pathway activation, apoptosis, and treatment sensitivity. This article connects its pharmacology with MDM1-based chemoradiotherapy research to provide a practical framework for model selection, combination assays, and interpretation.
-
Fluoxetine HCl: Applied Neuroscience Workflows
2026-08-14
Fluoxetine HCl connects transporter pharmacology with receptor-current assays, neurogenesis and synaptic plasticity studies, and translational motivation paradigms. This workflow-focused guide shows how to formulate, dose, validate, and troubleshoot the compound without confusing acute serotonergic effects with developmental or behavioral conclusions.
-
Sumatriptan Metabolism: CYP and MAO Revisited
2026-08-13
The reference study revisits the accepted metabolic pathway of sumatriptan and shows that cytochrome P450 enzymes can contribute to N-demethylation alongside monoamine oxidase A. Its recombinant-enzyme and HPLC–MS design identifies a sequential CYP–MAO pathway that refines interpretation of sumatriptan biotransformation and drug-metabolite exposure.
-
Nocodazole for Microtubule Dynamics Research
2026-08-13
Nocodazole provides a reversible way to perturb microtubule assembly, making it useful for trafficking, cell-cycle, cancer, and pathogen-entry assays. This workflow translates findings from Spiroplasma eriocheiris infection research into practical controls for separating cytoskeletal dependence from nonspecific toxicity.
-
Pioglitazone: PPARγ Assays and Workflow Guide
2026-08-12
Use Pioglitazone as a controlled PPARγ agonist to connect metabolic signaling with macrophage polarization, intestinal inflammation, and beta-cell protection. This guide translates published DSS-model findings into practical cell, tissue, and troubleshooting workflows while separating evidence-backed parameters from optimization starting points.
-
Tetrandrine Workflows for Ion Channel Research
2026-08-12
Tetrandrine combines calcium-channel activity with practical DMSO handling for cell-based, biochemical, and membrane-transport assays. This guide turns its formulation and pharmacology into reproducible workflows, while using natural-product screening principles to improve controls and interpretation.
-
3-(1-methylpyrrolidin-2-yl)pyridine (N2703) Workflows
2026-08-11
Build more interpretable pathway, signaling, and analytical assays with 3-(1-methylpyrrolidin-2-yl)pyridine (N2703). This guide emphasizes concentration design, pathway reconstitution, product verification, and troubleshooting rather than treating a small molecule as a substitute for genetic or biochemical evidence.
-
3-Deazaadenosine and the Methylation Control Point
2026-08-11
A translational perspective on how 3-Deazaadenosine converts SAH hydrolase inhibition into a systems-level methylation perturbation, and how that tool can help connect m6A biology, fibrosis mechanisms, and preclinical antiviral research without overstating pathway specificity.
-
Sodium Citrate B7298 for Reliable Cell Assays
2026-08-10
Learn how Sodium Citrate (SKU B7298) can improve control of pH, divalent-metal availability, and reagent handling in cell viability, proliferation, cytotoxicity, and biochemical workflows. This scenario-based guide separates validated product specifications from assay-specific recommendations and explains how to qualify citrate without masking biological effects.
-
Entinostat: Measuring Cancer Drug Response Better
2026-08-09
Entinostat (MS-275) is a selective class I HDAC inhibitor with broad relevance to cancer research. This guide explains how to distinguish growth arrest from cell killing so HDAC-response assays produce more interpretable biological and translational data.
-
Simvastatin (Zocor) Research Workflows
2026-08-08
Simvastatin (Zocor) supports reproducible studies of cholesterol biosynthesis, hepatic cancer phenotypes, endothelial signaling, and drug transport. This practical guide combines formulation control, time-resolved assay design, and reference-informed troubleshooting for stronger lipid and apoptosis readouts.
-
Ibrexafungerp: From pH Biology to Assay Design
2026-08-07
Ibrexafungerp is an oral triterpenoid antifungal with activity against Candida under clinically relevant acidic conditions. This article translates pH-sensitive susceptibility data into a practical framework for assay selection, resistance interpretation, and preclinical model design.
-
Phosbind Acrylamide: Precision Protein Phosphorylation Analy
2026-08-07
Phos binding reagent (Phosbind) acrylamide streamlines antibody-free detection of phosphorylated proteins in SDS-PAGE, offering clear mobility shifts and reliable results for protein phosphorylation signaling research. Discover how optimized workflows and troubleshooting insights can elevate your kinase pathway studies using this phosphate-binding reagent.
-
Small Molecules Boost Pancreatic Ductal Organoid Generation
2026-08-06
This study introduces a robust protocol that employs a cocktail of small molecules to significantly improve the efficiency and stability of pancreatic ductal organoid (PDO) cultures. The findings establish a reproducible system for modeling pancreatic diseases and facilitate high-throughput drug screening in regenerative medicine.
-
Isoprinosine in Immunotherapy: Optimizing Viral Inhibition W
2026-08-06
Isoprinosine (inosine pranobex) stands out as an immunomodulatory agent that merges direct antiviral effects with immune enhancement, offering a strategic edge in research on viral infection and immunotherapy. This article delivers actionable workflow guidance, advanced troubleshooting strategies, and leverages new insights from herpesvirus nuclear egress biology to maximize assay success.